Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I wonder if ...

"Please note that, per Cliff, Opty has contributed more to the success of PTSC than ANY other shareholder (at least during his tenure)."

A sad situation when a shareholder is compelled to contribute to the success of an enterprise instead of those being richly compensated for supposedly doing so. And in this case, a shareholder who perhaps, like many of us, has lost 90% of his investment, is championed by the CEO for "the success of PTSC" ............. exactly what "success"? How patronizing! Yet another example of the complete aloofness, arrogance, and ineptness of the 3 amigos. The neck of the bottle remains at the top.

an aside --- PTSC reported its annual K on August 29 last year.

Share
New Message
Please login to post a reply